Thomas R. Insel, M.D.Director, National Institute of Mental Health (NIMH) and Chair of the IACC
Dr. Thomas Insel has served as Chair of the IACC since it was first convened in January 2007 after being reconstituted under the Combating Autism Act of 2006. Dr. Insel is the Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health charged with generating the knowledge needed to understand, treat, and prevent mental disorders. NIMH is home to a large autism research program that covers a wide variety of topics including diagnosis, basic biology, genetics, treatment and prevention, epidemiology, health services research and outcomes of autism across the lifespan. Prior to his appointment as NIMH Director in 2002, Dr. Insel was a Professor of Psychiatry at Emory University. There, he was founding Director of the Center for Behavioral Neuroscience, one of the largest science and technology centers funded by the National Science Foundation and, concurrently, Director of an NIH-funded Center for Autism Research. From 1994 to 1999, he was Director of the Yerkes Regional Primate Research Center in Atlanta. While at Emory, Dr. Insel continued the line of research he had initiated at NIMH studying the neurobiology of complex social behaviors. He has published over 250 scientific articles and four books, including the Neurobiology of Parental Care (with Michael Numan) in 2003. Dr. Insel graduated from the combined B.A.-M.D. program at Boston University.
James F. Battey, M.D., Ph.D.Director, National Institute on Deafness and Other Communication Disorders (NIDCD)
Dr. James Battey has served as a Federal member of the IACC since 2007. He is the Director of the National Institute on Deafness and Other Communication Disorders (NIDCD) at NIH. The Institute supports biomedical and behavioral research and research training in the normal and disordered processes of hearing, balance, smell, taste, voice, speech, and language. Dr. Battey is widely recognized for his work on G-protein coupled receptors (GPCRs), a large family of proteins important in cell-to-cell communication, and integral to an array of physiological processes, including taste and smell, vision, immune response, and the transmission of messages between nerve cells. Much of his research has focused on mammalian bombesin receptors-GPCRs that mediate such processes as hormone release, smooth muscle contraction, and cell division-and he has collaborated on a large-scale project to identify molecules that are important for taste. Dr. Battey was appointed Director of the Intramural Research Program for NIDCD in 1995 and has served as the Director of NIDCD since 1998. He received his undergraduate education at the California Institute of Technology, where he earned his B.S. with honors in physics. He earned his M.D. and Ph.D. in Biophysics from Stanford University, where he also received residency training in Pediatrics.
Linda Birnbaum, Ph.D.Director, National Institute of Environmental Health Sciences (NIEHS)
Dr. Linda Birnbaum joined the IACC as a Federal member in 2009 and is Director of the National Institute of Environmental Health Sciences at NIH and the National Toxicology Program (NTP). As NIEHS and NTP Director, Birnbaum oversees a budget of $850 million that funds biomedical research to discover how the environment influences human health and disease. A board-certified toxicologist, Dr. Birnbaum has served as a Federal scientist for 31 years. Prior to her appointment as NIEHS and NTP Director, she spent 19 years at the Environmental Protection Agency where she directed the largest division focusing on environmental health research. Birnbaum started her Federal career with 10 years at the NIEHS - first as a senior staff fellow in the National Toxicology Program, then as a Principal Investigator and research microbiologist, and finally as a group leader for the Institute's Chemical Disposition Group. Birnbaum is also an active member of the scientific community. She was Vice President of the International Union of Toxicology, the umbrella organization for toxicology societies in more than 50 countries; former President of the Society of Toxicology, the largest professional organization of toxicologists in the world; former Chair of the Division of Toxicology at the American Society of Pharmacology and Therapeutics; and former Vice President of the American Aging Association. Dr. Birnbaum's own research focuses on the pharmacokinetic behavior of environmental chemicals, mechanisms of actions of toxicants, including endocrine disruption, and linking of real-world exposures to effects. She is the author of more than 700 peer-reviewed publications, book chapters, abstracts and reports. In addition to her role at NIEHS, she is also an adjunct professor in the Gillings School of Global Public Health, the Curriculum in Toxicology, and the Department of Environmental Sciences and Engineering at the University of North Carolina at Chapel Hill, as well as in the Integrated Toxicology Program at Duke University. In October 2010, she was elected to the Institute of Medicine of the National Academies, one of the highest honors in the fields of medicine and health. Dr. Birnbaum received her M.S. and Ph.D. in Microbiology from the University of Illinois at Urbana-Champaign.
Coleen A. Boyle, Ph.D., M.S. Hyg.Director, National Center on Birth Defects and Developmental Disabilities and Director (NCBDDD)
Dr. Boyle joined the IACC as a Federal member in 2010 after she was named Director of the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the Centers for Disease Control and Prevention (CDC). Before joining CDC in 1984, Dr. Boyle served as a faculty member in epidemiology at the University of Massachusetts, Program in Public Health. Dr. Boyle began her career at CDC working on a large multi-faceted project to examine the impact of Agent Orange exposure on U.S. military personnel who served in Vietnam. Dr. Boyle joined the Division of Birth Defects and Developmental Disabilities, in 1988, was appointed Chief of the Surveillance and Epidemiology Section in the Developmental Disabilities Branch in 1991 and assumed the responsibilities of the Branch Chief in 1995 focusing on epidemiology of major developmental disabilities including cerebral palsy and intellectual disabilities. In 2001, Dr. Boyle was named the Associate Director for Science and Public Health for the newly created National Center for Birth Defects and Developmental Disabilities (NCBDDD) at CDC. In that role, Dr. Boyle was responsible for developing and coordinating the science activities of the National Center. In October 2004, Dr. Boyle was appointed Director of the Division of Birth Defects and Developmental Disabilities, NCBDDD. The Division has a budget of $60 million and focuses on surveillance, epidemiology research and prevention of major birth defects and developmental disabilities. Dr. Boyle is the recipient of the CDC Charles C. Shepard Award for scientific excellence in 1997 and 2004 and has authored or co-authored more than 100 scientific peer-reviewed and other scientific publications. Dr. Boyle received her M.S. (hyg.) in Biostatistics and Ph.D. in Epidemiology from the University of Pittsburgh School of Public Health and completed postdoctoral training in Epidemiologic Methods at Yale University.
Francis S. Collins, M.D., Ph.D.Director, National Institutes of Health (NIH)
Francis S. Collins, M.D., Ph.D., joined the IACC as a Federal member in 2009, following his appointment as the 16th Director of the National Institutes of Health (NIH) in August 2009. Dr. Collins, a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, served as Director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993-2008. With Dr. Collins at the helm, the Human Genome Project consistently met projected milestones ahead of schedule and under budget. This remarkable international project culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. On March 10, 2010, Dr. Collins was named a co-recipient of the Albany Medical Center Prize in Medicine and Biomedical Research for his leading role in this effort. In addition to his achievements as the NHGRI director, Dr. Collins' own research laboratory has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington's disease, a familial endocrine cancer syndrome, and most recently, genes for type 2 diabetes and the gene that causes Hutchinson-Gilford progeria syndrome. Prior to coming to the NIH in 1993, he spent nine years on the faculty of the University of Michigan, where he was a Howard Hughes Medical Institute Investigator. He is an elected member of the Institute of Medicine and the National Academy of Sciences. Dr. Collins was awarded the Presidential Medal of Freedom in 2007. In a White House ceremony on October 7, 2009, Dr. Collins received the National Medal of Science, the highest honor bestowed on scientists by the United States government. Dr. Collins received a B.S. in Chemistry from the University of Virginia, a Ph.D. in Physical Chemistry from Yale University, and an M.D. with honors from the University of North Carolina at Chapel Hill.
Tiffany R. Farchione, M.D.Medical Officer, Division of Psychiatry Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA)
Dr. Farchione is a Medical Officer in the Division of Psychiatry Products, Center for Drug Evaluation and Research at the US Food and Drug Administration. As such, she is responsible for the clinical review of psychiatric drug development activities conducted under INDs and of NDAs and supplements for new psychiatric drug claims. Prior to coming to FDA in 2010, Dr. Farchione was affiliated with the University of Pittsburgh Medical Center, and was on the faculty of the University of Pittsburgh. Dr. Farchione received her medical degree from Wayne State University in Detroit, Michigan, and completed adult residency and child & adolescent fellowship training at the University of Pittsburgh's Western Psychiatric Institute and Clinic. Dr. Farchione is board certified in both general and child & adolescent psychiatry.
Alan E. Guttmacher, M.D.Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Dr. Alan Guttmacher joined the IACC as a Federal member in 2009. Dr. Guttmacher is Acting Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development at NIH, which supports research on all stages of human development, from preconception to adulthood, to better understand the health of children, adults, families, and communities. Prior to his appointment at as Director of NICHD, Dr. Guttmacher served as Acting Director of NICHD, and prior to that, as the Deputy Director and then Acting Director of the National Human Genome Research Institute (NHGRI). At NHGRI, he oversaw the Institute's efforts to advance genome research, integrate that research into medical practice, and explore the ethical, legal, and social implications of human genomics. Dr. Guttmacher came to the NIH from the University of Vermont, where he directed the Department of Pediatrics' Vermont Regional Genetics Center and Pregnancy Risk Information Service. His research interests have been dysmorphology (abnormalities of development), and the identification and description of syndromes. He also has an interest in hereditary hemorrhagic telangiectasia - a condition resulting in numerous malformations of the blood vessels. Dr. Guttmacher received an A.B. degree from Harvard College and an M.D. from Harvard Medical School.
Laura Kavanagh, M.P.P.Director, Division of MCH Workforce Development, Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration (HRSA)
Laura Kavanagh, MPP is Director, Division of MCH Workforce Development, Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration. She oversees MCHB's interdisciplinary clinical training programs, MCH workforce development efforts, and the Healthy Tomorrows Partnership for Children Program. She is also the director of the Combating Autism Act Initiative, a cross-division program that includes research, training, and state demonstration projects, and a national evaluation. She is responsible for managing 160 projects with a $45 million annual budget. She is a graduate of the University of Virginia (Echols Scholar) and Georgetown University, where she received a master's degree in public policy with an emphasis on health policy analysis. Selected awards include American Academy of Pediatrics Section on Developmental & Behavioral Pediatrics 2011 Dale Richmond/Justin Coleman Lectureship Award; National Public Health Leadership Institute Fellow (2008-2009); and American Public Health Association's Maternal and Child Health Young Professional Award (1998).
Donna M. Kimbark, Ph.D.Program Manager, Autism Research Program, Congressionally Directed Medical Research Programs U.S. Department of Defense (DoD)
Dr. Donna Kimbark joined the IACC as a Federal member in 2012. Dr. Kimbark is the Program Manager for the Congressionally Directed Medical Research Programs at the Department of Defense, a complex extramural biomedical research program that includes the DOD Autism Research Program (ARP), DOD Bone Marrow Failure Research Program (BMFRP), the Multiple Sclerosis Research Program (MSRP) and the Peer Reviewed Cancer Research Program. She oversees the management of 214 research awards representing $136.25 million in appropriated funds. Dr. Kimbark holds a Ph.D. in Molecular Pharmacology and Cancer Therapeutics from State University of New York, Albany.
Walter J. Koroshetz, M.D.Deputy Director, National Institute of Neurological Disorders and Stroke (NINDS)
Dr. Walter Koroshetz joined the IACC as a Federal member in 2009. He is Deputy Director of the National Institute of Neurological Disorders and Stroke (NINDS). He works with the NINDS Director in program planning and budgeting, and oversees Institute scientific and administrative functions. Before joining NINDS, Dr. Koroshetz served as Vice Chair of the Neurology Service and Director of Stroke and Neurointensive Care Services at Massachusetts General Hospital (MGH). He was also a Professor of Neurology at Harvard Medical School and led neurology resident training at MGH between 1990 and 2007. Dr. Koroshetz trained in neurology at MGH, after which he did post-doctoral studies in cellular neurophysiology at MGH and the Harvard neurobiology department. He joined the neurology staff, first in the Huntington's disease unit and then in the stroke and neurointensive care service. A native of Brooklyn, New York, Dr. Koroshetz graduated from Georgetown University and received his medical degree from the University of Chicago. He trained in Internal Medicine at the University of Chicago and Massachusetts General Hospital before specializing in Neurology.
Sharon LewisSenior Advisor on Disability Policy, U.S. Department of Health and Human Services; Principal Deputy Administrator, Administration for Community Living (ACL)
Sharon Lewis joined the IACC as a Federal member in 2010 following her appointment as Commissioner of the Administration on Developmental Disabilities in March 2010. In 2012, Ms. Lewis was named Commissioner of the Administration on Developmental and Intellectual Disabilities within the new Administration for Community Living at the Department of Health and Human Services. In 2013, Ms. Lewis became Acting Deputy Principal Administrator of the Administration for Community Living. Well known as an effective advocate, Sharon has a proven track record in championing disability issues, while working for a better quality of life for all. Ms. Lewis has worked in disability policy for more than 10 years at local, state, and national levels. She originally came to Washington, D.C. to serve as a Joseph P. Kennedy, Jr. Foundation Public Policy Fellow, working for Senator Chris Dodd's HELP subcommittee on Children and Families. In 2007, she joined Chairman George Miller's Education & Labor Committee staff as Senior Disability Policy Advisor, where she advised members of the Committee on disability concerns related to education, employment and healthcare. Ms. Lewis is the recipient of numerous awards, including the 2010 Distinguished Leadership in National Disability Policy Award and the Consortium for Citizens with Disabilities Chairman's Award. In Oregon, Ms. Lewis worked on public policy for the Oregon Developmental Disabilities Coalition and for the Arc. She served as the Co-Chair of the Oregon Family Action Coalition Team, founded DisabilityCompass.org and managed the Oregon Partners in Policymaking Program, working with individuals with disabilities and family members to participate in policy decisions at all levels. Ms. Lewis is a parent to three daughters, including one with disability. She is a native of Michigan and a graduate of Washington University in St. Louis.
John P. O'Brien, M.A.Senior Policy Advisor for the Disabled and Elderly Health Programs Group Centers for Medicare & Medicaid Services
Mr. John O'Brien joined the IACC as a Federal member in 2012. Mr. O'Brien is the Senior Policy Advisor for the Disabled and Elderly Health Programs Group at the Centers for Medicare & Medicaid Services. Previously, John was the Senior Advisor to the Administrator on Health Care Reform at the Substance Abuse and Mental Health Services Administration (SAMHSA). Mr. O'Brien was the Director of several national projects funded by the Robert Wood Johnson Foundation to develop strategies for coordinating funding for human services from federal, state and local dollars. Prior to his work at SAMHSA, Mr. O'Brien worked with the Technical Assistance Collaborative for fifteen years as a Senior Consultant. He has provided consultation to over 30 states and local human services authorities. He has worked with Medicaid, state mental health and substance abuse authorities. He has worked with states to develop federal Medicaid Waivers, Medicaid state plan amendments, and federal grant applications (e.g., children's system of care). Mr. O'Brien has also been a manager at KPMG Peat Marwick and worked for the Eunice Kennedy Shriver Center, the Massachusetts Developmental Disability Council, the Illinois Governor's Office, and the Illinois Legislative Commission on Mental Health, Mental Retardation and Substance Abuse. He was a program staff at Thresholds, Inc. in Chicago. Mr. O'Brien holds a bachelor's degree from Loyola University and a Master of Arts degree with a concentration in public policy from University of Chicago.
Linda K. SmithDeputy Assistant Secretary and Inter-Departmental Liaison for Early Childhood Development for the Administration for Children and Families (ACF)
Ms. Smith joined the IACC as a Federal member in 2013. As Deputy Assistant Secretary and Inter-Developmental Liaison for ACF, she provides overall policy coordination for the Head Start and Early Head Start Program and the Child Care and Development Fund, as well as serving as the liaison with the U.S. Department of Education and other federal agencies. Her office serves as a focal point for early childhood policy at the federal level. She previously served as the executive director for the National Association of Child Care Resource and Referral Agencies (NACCRRA), where she represented more than 650 community-based agencies concerned with the care of children in their earliest years. Ms. Smith led the organization through significant growth and transformation- she was the driving force behind NACCRRA's national policy agenda and strategic plan to improve the quality of child care nationwide. Key components of NACCRRA's advocacy efforts included strengthening child care licensing and oversight, requiring comprehensive background checks, and establishing minimum training requirements for all child care workers. Prior to joining NACCRRA, Ms. Smith served as a legislative fellow and professional staffer on the Senate Health, Education, Labor and Pensions Committee under the Chairmanship of the late Senator Edward M. Kennedy. Prior to this work, she was the director of the Office of Family Policy for the Secretary of Defense, where she was one of the primary architects of the military's child care program. Additionally, she has held positions with both the United States Army and United States Air Force. She began her career in early childhood education on the Northern Cheyenne Reservation in her native state of Montana. She is a graduate of the University of Montana.
Michael K. YudinActing Assistant Secretary for Special Education and Rehabilitative Services, U.S. Department of Education
Michael K. Yudin formerly served as the Principal Deputy Assistant Secretary for the Office of Elementary and Secondary Education (OESE). In this role, he helped lead policy development and operations of all grant programs administered by OESE designed to promote academic excellence and ensure equitable opportunities for educationally disadvantaged students. Mr. Yudin also helped lead the Department's efforts on Elementary and Secondary Education Act (ESEA) flexibility. He served as Acting Assistant Secretary for Elementary and Secondary Education from June 2011 to May 2012.
Prior to joining the Department of Education, Yudin spent nine years in the United States Senate, serving as legislative director for Senator Jeanne Shaheen of New Hampshire, senior counsel to Senator Jeff Bingaman of New Mexico, and HELP Committee counsel to Senator Jim Jeffords of Vermont. In these roles, he assisted in developing, promoting, and advancing a comprehensive legislative agenda related to education, children and families, disabilities, and poverty. Working for senior Members of the HELP Committee, Yudin helped draft, negotiate, and pass various pieces of legislation, including the No Child Left Behind Act, and IDEA 2004. He also worked on the reauthorizations of the Rehabilitation Act of 1973, Head Start, the Carl D. Perkins Vocational and Technical Education Act of 2006, and the Higher Education Act.
Before joining the Senate, Mr. Yudin served as an attorney at the Social Security Administration and at the U.S. Department of Labor for nearly ten years. In these positions, he provided legal advice on various policy initiatives, including social security, disability, employment, and welfare reform. He also served as director of employment policy for two leading national disability organizations: the ARC of the United States and United Cerebral Palsy (UCP).
Idil AbdullParent and Co-Founder of the Somali American Autism Foundation
Ms. Idil Abdull joined the IACC as a public member in 2012. Ms. Abdull is the parent of a son with autism and Co-Founder of the Somali American Autism Foundation. As a Somali-American mother, she has worked to raise awareness about the high prevalence of autism among Somali immigrants living in Minnesota and has helped to change autism policies in the state. Her work as a vocal advocate for the community has received national media coverage and her testimony before the IACC resulted in a joint research initiative between the Centers for Disease Control and Prevention, the National Institutes of Health, and Autism Speaks to investigate ASD rates among Somali-American children. Ms. Abdul strives to give a voice to children with classic autism and to ensure that someday parents will have access to effective treatments and an understanding of what caused their child's autism. She also has a special interest in serving as a voice for underrepresented groups more broadly, including those that are struggling with language, cultural, and economic barriers as they seek ways to help their family members with disabilities. She encourages the research community to investigate why certain ethnic groups may be more susceptible to autism and how genes interact with the environment to influence risk. Ms. Abdull is also passionate about finding ways to improve the system of services and supports so that families can receive coverage for the early intervention and lifespan services they need. In addition to her work through the Somali American Autism Foundation, she serves on the Minnesota Autism Task Force. Ms. Abdull holds a bachelor's degree in Health Care Administration.
James Ball, Ed.D., B.C.B.A.-D.President and CEO of JB Autism Consulting and Chair, Autism Society Board of Directors
Dr. Jim Ball joined the IACC as a public member in 2012. Dr. Ball is a Board Certified Behavior Analyst (BCBA-D) who is the President and CEO of JB Autism Consulting. He has worked in the private sector field of autism for more than 25 years, providing educational, employment, and residential services to children and adults affected with autism. Dr. Ball has lectured nationally and internationally, provided expert testimony, and published in the areas of early intervention, behavior, consultation services, social skills, technology, and trauma. He is a featured author and is on the advisory board for the Autism Asperger's Digest magazine. His 2008 triple Award Winning book, "Early Intervention & Autism: Real-Life Questions, Real-Life Answers" was released in February of 2008. Dr. Ball, a former Board of Trustee member for the New Jersey Center for Outreach and Services for the Autism Community (COSAC), now Autism New Jersey, is also a member of the COSAC/Autism NJ Professional Advisory Board. He is a Board member of the Autism Society's Board of Directors and is currently the Chair of the National Board. Prior to that, Dr. Ball assisted the Autism Society's Board as the Co-Chair of the AS Panel of Professional Advisors (2005-2009). Dr. Ball has won numerous awards, including NYFAC's Autism Inspiration Award, Autism Society's Literary Work of the Year for his manual on social security and employment for individuals with autism spectrum disorders, and Autism New Jersey's highest honor, its Distinguished Service Award. He received his Doctor of Education degree from Nova Southeastern University in Fort Lauderdale, Florida.
Anshu Batra, M.D.Parent and Developmental Pediatrician, Our Special Kids
Dr. Anshu Batra joined the IACC as a public member in 2012. Dr. Batra is a developmental pediatrician specializing in autism and early childhood developmental disorders and the mother of two sons with autism spectrum disorder. She currently works in a private practice that provides medical services to more than 600 patients with developmental disabilities, the majority of whom have an autism diagnosis. The practice is unique not only in terms of the racial, ethnic, and socio-economic diversity of its patients, but also in its scope. Dr. Batra provides comprehensive management for a patient population that ranges from baby siblings to older adults who are being cared for by family members. In her practice, she addresses complex issues that emerge for both patients and their caregivers over the lifespan. Dr. Batra has become an outspoken advocate to educate both the professional and lay communities about autism and considers how to best integrate a growing subpopulation of individuals on the spectrum into society. She has appeared on national programs such as the Oprah Winfrey Show, The View, and House Calls with Dr Sanjay Gupta to speak about the diagnosis and management of autism. In addition, she works to educate the community about the unique challenges faced by children and adults with disabilities within their communities, and to promote tolerance and patience in the community response. She is a well-recognized advocate in the Los Angeles area, where she serves on the Board of Directors for the Los Angeles Chapter of Autism Speaks. She has served as an ad hoc Member for the National Institute of Mental Health (NIMH) Special Emphasis Review Panel for the Heterogeneity of Autism Spectrum Disorders initiative funded by NIH under the American Recovery and Reinvestment Act, the California Senate Select Committee on Autism and Related Disorders, South Los Angeles Regional Task Force Insurance Subcommittee, and on the Autism Technical Expert Panel to develop the RAND Evidence Based Practice Guidelines for the treatment of Autism. She received her M.D. from the University of Michigan and trained in pediatrics at the University of North Carolina, Chapel Hill.
Noah Britton. M.A.Self Advocate and Adjunct Professor of Psychology, Bunker Hill Community College
Mr. Noah Britton joined the IACC as a public member in 2012. Mr. Britton was diagnosed with Asperger's syndrome a decade ago as a freshman in college and has spent every year since working directly with people on the autism spectrum. He currently serves as an Adjunct Professor of Psychology at Bunker Hill Community College in Boston, Massachusetts and has presented on autism as a guest lecturer at the University of Virginia and Tufts University. Prior to that Mr. Britton worked directly with teenagers on the spectrum as head counselor for the Northeast ARC's Spotlight program and as a drama teacher at the New England Academy in Massachusetts. He has conducted significant research on causes and interventions for ASD and co-authored a forthcoming encyclopedia chapter. As an autistic self-advocate, Mr. Britton feels strongly that communities need to address the abusive treatment of people with ASD and ensure that they have access to effective interventions. A skilled communicator, he is able to act as a bridge between the autistic and neurotypical world, explaining the concrete meaning behind the expectations of neurotypicals or other autistics. Mr. Britton currently serves on the scientific/educational advisory board of the Autism Higher Education Foundation. He received his master's degree in psychology from Hunter College in 2010.
Sally Burton-Hoyle, Ed.D.Family Member and Associate Professor of Special Education, Eastern Michigan University
Dr. Sally Burton-Hoyle joined the IACC as a public member in 2012. Dr. Burton-Hoyle, sister to a person on the autism spectrum, has focused her life and career on improving the education of people with autism and other challenging behaviors. She serves as area coordinator of the Masters of Autism Spectrum Disorders program at Eastern Michigan University (EMU). This program is based on Positive Behavioral Supports and family/community involvement. Dr. Burton-Hoyle has been at EMU since 2006 and was Executive Director of the Autism Society of Michigan prior to EMU. She has previously served as a lecturer on autism at Oakland University, the Associate Director of the Idaho Center on Developmental Disabilities, and an instructor at the University of Idaho and Washington State University. In addition, she has classroom experience as a special education teacher. Dr. Burton-Hoyle is a sought-after presenter and consultant in the area of special education, autism, and challenging behavior and as the mother of three boys, she has learned to reframe all behavior as communication. She brings years of experience in working with people with autism spectrum disorders and is well grounded in the diagnostic and therapeutic trends of the day and has a balanced view of the history of the condition and how therapeutic trends have evolved. She was recently recognized for her outstanding service to Eastern Michigan University. Dr. Burton-Hoyle holds a Doctor of Education degree from the University of Idaho and a master's degree in special education from the University of Kansas.
Matthew J. Carey, Ph.D.Parent and Autism Blogger
Dr. Matt Carey joined the IACC as a public member in 2012. Dr. Carey is the father of a young child with multiple disabilities, including autism spectrum disorder, and is a frequent contributor to the Left Brain/Right Brain blog and other autism blogs. His writing focuses on reviewing current autism research in an understandable way for the public and he is deeply committed to communicating the importance of getting the science right for autism. He is also interested in analyzing trends in health and education public datasets; his critique of "Timing of Increased Autistic Disorder Cumulative Incidence" was published in the journal Environmental Science & Technology and his analysis of parents' academic expectations for their children with ASD, based on the 2007 National Household Education Survey, was presented at a poster session during the 2011 International Meeting For Autism Research (IMFAR). Dr. Carey is an active industrial researcher in computer hardware whose current research interests include magnetic thin films, spintronics, and magnetic nanostructures. His work has been published in high-impact journals such as Nature Materials, Physical Review Letters, and Applied Physics Letters and he currently holds 106 patents or published patent applications. He received his B.S. in physics from Harvey Mudd College, his M.S. in Physics from the University of Illinois, Urbana-Champaign and his Ph.D. in Physics from the University of California, San Diego.
Wendy Chung, M.D., Ph.D.Director of Clinical Research, Simons Foundation
Dr. Wendy Chung joined the IACC as a public member in 2014. Dr. Chung is the Director of Clinical Research at the Simons Foundation Autism Research Initiative (SFARI), as well as the Herbert Irving Associate Professor of Pediatrics and Medicine at Columbia University College of Physicians and Surgeons and Director of Clinical Genetics at Columbia University, where she is the principal investigator for the Simons Variation in Individuals Project (Simons VIP), funded by the Simons Foundation. Dr. Chung previously served as a member of SFARI's scientific advisory board. She was the recipient of the American Academy of Pediatrics Young Investigator Award, the Medical Achievement Award from Bonei Olam, and a career development award from Doris Duke. Dr. Chung is a member of the Glenda Garvey Teaching Academy and has won many awards for teaching including the Charles W. Bohmfalk Award for Distinguished Contributions to Teaching, American Medical Women's Association Mentor Award, and Columbia University Presidential Award for Outstanding Teaching. She received her B.A. in biochemistry and economics from Cornell University, her M.D. from Cornell University Medical College, and her Ph.D. from The Rockefeller University in genetics.
Jose F. Cordero, M.D., M.P.H.Pediatrician, Epidemiologist and Dean of the Graduate School of Public Health, University of Puerto Rico
Dr. Jose Cordero joined the IACC as a public member in 2012. Dr. Cordero has been the Dean of the Graduate School of Public Health at the University of Puerto Rico since August 2006. Prior to this appointment, Dr. Cordero worked for 27 years at the CDC and has extensive public health experience in the fields of birth defects, developmental disabilities, and child health. Dr. Cordero was an Assistant Surgeon General of the Public Health Service and the Founding Director of the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. NCBDDD was created by the Children's Health Act of 2000. In a few years, NCBDDD became a leading international institution devoted to research and prevention of birth defects and developmental disabilities and health promotion of people of ages living with disabilities. Dr. Cordero has also promoted research to determine the causes of birth defects and developmental disabilities, and has promoted efforts to prevent serious birth defects (such as use of folic acid to prevent spina bifida). He is a strong supporter of programs that promote wellness of persons with disabilities. A native of Puerto Rico, Dr. Cordero obtained his medical degree from the University of Puerto Rico in 1973.He completed residency training in pediatrics at Boston City Hospital and a fellowship in medical genetics at the Massachusetts General Hospital.
Jan M. CrandyParent, Case Manager, Nevada State Autism Treatment Assistance Program, Chair, Nevada Commission on Autism Spectrum Disorders and Co-Founder, Families for Effective Autism Treatment
Ms. Jan Crandy joined the IACC as a public member in 2012. Ms. Crandy is a case manager for the Nevada State Autism Treatment Assistance Program (ATAP) and has been a leader in raising awareness and treating autism spectrum disorders in Nevada for more than 15 years. She is a dedicated advocate and parent of a child with autism. In her current position at ATAP, Ms. Crandy manages and develops programs for more than 65 children with ASD. In 2007, Ms. Crandy was appointed to the Nevada Autism Task Force by Governor Jim Gibbons. In that role, Ms. Crandy helped develop policy recommendations for state policymakers on ways to improve the delivery and coordination of autism services in Nevada. For example, Ms. Candy worked with the Nevada legislature to expand the eligibility criteria for autism to include PDD-NOS, so that all children within the spectrum of autism could be counted and receive associated services. She also serves as Chair of the Nevada Commission on Autism Spectrum Disorders and was selected as a White House Community Leader to attend the White House briefings in 2011. Ms. Crandy began her career in advocacy in 1996 when her daughter was diagnosed with autism. With the support of family and friends, Ms. Crandy started a nonprofit organization called Families for Early Autism Treatment (FEAT) to help parents of children with ASD in Southern Nevada.
Geraldine Dawson, Ph.D.Professor of Psychiatry and Behavioral Sciences, Duke University Medical Center
Dr. Geraldine Dawson joined the IACC as a public member in 2010. She holds joint appointments as a Professor in the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center and the Duke Institute for Brain Sciences. She holds secondary appointments in the Department of Pediatrics and the Department of Psychology & Neuroscience at the university. Dr. Dawson also is leading the Duke Autism Program and the development of a new multi-disciplinary autism diagnostic and treatment center with a signature focus on diagnosis and treatment of infants, toddlers and preschoolers, as well as co-leading the establishment of a Center for Children's Social and Emotional Health within Duke's Integrated Pediatric Mental Health Program. Previously, Dr. Dawson was the Chief Science Officer for Autism Speaks, where she worked with the scientific community and other stakeholders to shape and expand the organization's scientific vision. In addition to her work with Autism Speaks, Dr. Dawson previously was Research Professor of Psychiatry at the University of North Carolina at Chapel Hill, Adjunct Professor of Psychiatry at Columbia University, and Professor Emeritus of Psychology at University of Washington. Dr. Dawson is a licensed clinical psychologist who has published extensively on autism spectrum disorders, focusing on early detection and intervention and early patterns of brain dysfunction (using electrophysiology). In collaboration with Dr. Sally Rogers, Dr. Dawson helped to develop and empirically-validated the Early Start Denver Model, the first comprehensive early intervention program for toddlers with autism. She has collaborated on numerous studies of brain development and function and genetic risk factors in autism. From 1996-2008, Dr. Dawson was Founding Director of the University of Washington Autism Center where she directed three National Institutes of Health (NIH) Autism Center of Excellence Award programs of research focusing on genetics, neuroimaging, early diagnosis, and clinical trials. At the Center, she also oversaw multi-disciplinary diagnostic and treatment services for children with autism from infancy through late adolescence. Dr. Dawson has been a consultant to the NIH since 1989, including participating on the NIH Committee on Practice Parameters for Screening and Diagnosis of Autism, NIH Scientific Advisory Panel to establish a 10 year road map for autism research, the NIH Consensus Panel on Phenylketonuria, and three NIH Grant Review Committees. Dr. Dawson is a Fellow of the American Psychological Society, American Psychological Association, and the Society of Clinical Child and Adolescent Psychology. Dr. Dawson's honors include the Autism Society of America Award for Valuable Service, Washington Autism Society Achievement Award for Outstanding Service, Autism Society of Washington Medical Professional of the Year, Autism Society of America Award for Research Contributions, and the Autism Hero Award from Cure Autism Now. Dr. Dawson received her Ph.D. in Developmental Psychology with a minor in Child Clinical Psychology from the University of Washington.
David S. Mandell, Sc.D.Associate Professor of Psychiatry and Pediatrics, University of Pennsylvania School of Medicine
Dr. David Mandell joined the IACC as a public member in 2012. Dr. Mandell is a health services researcher and psychiatric epidemiologist who seeks to identify the best ways to organize, finance and deliver services to children with psychiatric and developmental disabilities. He currently serves as an Associate Professor of Psychiatry and Pediatrics at the University of Pennsylvania's School of Medicine. The goal of his current research is to improve care for children with autism and their families by developing successful interventions at the individual, provider and system levels to decrease the age at which children with autism are recognized and enter treatment, and to improve the services and supports available to them and their families. Specific studies include an examination of the relationship between states' policies and their delivery of health services to children with autism; the prevalence of undiagnosed autism among psychiatrically hospitalized adults; and, in partnership with the School District of Philadelphia, the largest randomized trial to date of a behavioral intervention for children with autism. Dr. Mandell co-chaired the Commonwealth of Pennsylvania's Autism Task Force from 2003 to 2006 and consults with the Department of Public Welfare to help them develop appropriate policies to meet the needs of families of children with autism. He also served as a member of the planning team for the Philadelphia Mayor's Blue Ribbon Commission on Children's Behavioral Health in 2007. Dr. Mandell is the author of more than 60 peer-reviewed scientific publications, many of which examine correlates of unmet need among children with psychiatric and developmental disabilities and strategies for reducing disparities. He holds a Bachelor of Arts in psychology from Columbia University and a Doctor of Science from the Johns Hopkins School of Hygiene and Public Health.
Lyn Redwood, R.N., M.S.N.Parent, Co-Founder and Vice President, Coalition for SafeMinds and Co-Founder, National Autism Association
Ms. Lyn Redwood has served as a public member of the IACC since 2007. Ms. Redwood is Co-Founder and Executive Director of the Coalition for SafeMinds and Co-Founder of the National Autism Association. She became interested in autism research and advocacy when he son was diagnosed with Pervasive Developmental Disorder. In 2000, Ms. Redwood testified before the Government Reform Committee on "Mercury in medicine: Are we taking unnecessary risks?" and before a Congressional sub-committee on health in 2003. She has published in the journals Neurotoxicology, Molecular Psychiatry, Expert Opinion in Pharmacotherapy, American Journal of Medical Genetics, Medical Hypotheses, Mothering Magazine, and Autism-Aspergers Digest. She has appeared on high-profile national programs such as "Good Morning America," the Montel Williams Show, and has been interviewed by U.S News and World Report, Wired Magazine, People and numerous other publications. She is prominently featured in the award-winning book by David Kirby Evidence of Harm. Ms. Redwood served on the Department of Defense Autism Spectrum Disorder Research Program from 2007-2009 and was acknowledged for a decade of service by Spectrum Magazine as their Person of the Year in 2009.
Robert H. Ring, Ph.D.Chief Science Officer, Autism Speaks
Dr. Robert Ring joined the IACC as a public member in 2014. Dr. Ring currently serves as Chief Science Officer (CSO) for Autism Speaks, a role he has held since June 2013. Autism Speaks, founded in 2005, is the largest autism science and advocacy organization in the U.S. Dr. Ring, a neuroscientist by training, is responsible for leading the science program at Autism Speaks, which features a diverse portfolio of research investments targeting medical research on the underlying biology of ASD, diagnosis, treatment, etiology, public health, and innovative technologies. Dr. Ring also currently serves as the Chairman of the Board the foundation's innovative venture philanthropy arm Delivering Scientific Innovation for Autism (DELSIA) and leads Autism Speaks' collaborative partnership with the Simons Foundation to support a new international brain banking network called the Autism BrainNet. Dr. Ring joined Autism Speaks in 2011 as vice president and Head of Translational Research and was responsible for the launch of DELSIA. Prior to joining Autism Speaks, Dr. Ring served as Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Connecticut. Prior to Pfizer, Dr. Ring worked for more than 10 years in psychiatric medicine discovery and development at Wyeth Research. Dr. Ring holds separate adjunct faculty appointments in the Department of Psychiatry at Mount Sinai School of Medicine (New York) and the Department of Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia). He holds a Bachelor of Arts degree in both Fine Arts and Biology (double-major) from Westmont College in Santa Barbara, California, and a Doctor of Philosophy in Molecular Neurobiology from City of Hope National Medical Center in Southern California.
Scott Michael Robertson, Ph.D.Self Advocate and Co-Founder and Vice Chair of Development, Autistic Self Advocacy Network (ASAN)
Mr. Scott Michael Robertson joined the IACC as a public member in 2012. Mr. Robertson co-founded the Autistic Self Advocacy Network (ASAN) in 2006 and currently serves as ASAN's Vice Chair of Development. Mr. Robertson, an adult on the autism spectrum, is currently a Ph.D. Candidate in information sciences and technology at Penn State University's University Park campus. His research pursuits in the fields of disability studies, human-computer interaction, and computer supported work/learning focus on understanding and improving the lives of people with neurological and developmental disabilities. He has authored several peer-reviewed academic journal articles and conference papers on this subject. Beyond his research, Mr. Robertson has actively served the cross-disability and autism communities as a mentor, teacher, advocate, public speaker, and writer. Mr. Robertson serves as a member of the Advisory Board of the Pennsylvania Department of Public Welfare's Bureau of Autism Services, as the Graduate Student Representative to the Society for Disability Studies, as a member of the Board of Directors of ASCEND Group (The Asperger Syndrome Alliance for Greater Philadelphia), as a member of the Scientific and Educational Advisory Board of the Autism Higher Education Foundation, and as a co-investigator and a community representative of the Academic Autistic Spectrum Partnership In Research and Education (AASPIRE). Mr. Robertson has delivered numerous presentations on autism and other disabilities at conferences, schools, and associations throughout the U.S., including 12 keynote addresses. He has also previously taught and mentored adolescents and young adults with neurological and developmental disabilities, including youth on the autism spectrum. Mr. Robertson holds a bachelor's degree in computer science from Rensselaer Polytechnic Institute and a master's degree in human-computer interaction from Carnegie Mellon University.
John Elder RobisonNeurodiversity Scholar in Residence at the College of William & Mary, Self Advocate, Parent, Author
Mr. John Elder Robison joined the IACC as a public member in 2012. Mr. Robison is an adult on the autism spectrum who is best known for working to increase public understanding of autism, and helping schools, businesses and government accommodate and accept people with autism. He is committed to diversity and is a strong advocate for autism science and research. He believes people with autism deserve an equal opportunity at success in work and social life, and he is dedicated to that goal. Mr. Robison is active on numerous ASD-related boards and committees in the US, Canada, Europe, and Australia. He is currently the Neurodiversity Scholar in Residence at the College of William & Mary. In addition to his service on the IACC, Mr. Robison has served on the steering committee for the International Classification of Functioning, Disability and Health (ICF) Autism Core Set project, and on organizing committees for the International Society for Autism Research (INSAR), the Institute for Autism Research at Canelius College, panels and committees for the National Institutes of Health (NIH), and boards for the Centers for Disease Control and Prevention (CDC). Mr. Robison's books Look Me in the Eye and Be Different are some of the most widely read accounts of life with autism/Asperger's in the world. His newest book, Raising Cubby, comes out in paperback March 2014. His writing is translated into more than 15 languages, and sold in 70+ countries. He is published by Random House in the USA, Scribe, Random House and Harper Collins in Australia, and other presses around the world. In addition to his work as an autism advocate and author, Mr. Robison has had a lifelong interest in cars. He is the founder of JE Robison Service of Springfield, Massachusetts, a business that restores Rolls-Royce, Land Rover, Jaguar, Mercedes, and BMW automobiles. Earlier John worked as an engineer in music and electronics. He was the American engineer for Britannia Row Audio, the sound company formed by the musical group Pink Floyd. He is the creator of the signature illuminated, fire breathing, and rocket launching special effects guitars played by KISS.
Alison Tepper Singer, M.B.A.Parent/Family Member and Founder and President, Autism Science Foundation
Ms. Alison Singer has served as a public member on the committee since 2007 Ms. ASinger is Founder and President of the Autism Science Foundation, a not-for-profit organization launched in April 2009 to support autism research. The Autism Science Foundation supports autism research by providing funding and other assistance to scientists and organizations conducting, facilitating, publicizing and disseminating autism research. Ms. Singer is the mother of a child with autism and legal guardian of her adult brother with autism. From 2005-2009 she served as Executive Vice President and a Member of the Board of Directors at Autism Speaks. Ms. Singer also currently serves on the Executive Board of the Yale Child Study Center Associates Committee, on the external advisory board of the Autism Baby Siblings Research Consortium, on the external advisory board of the CDC's Center for Birth Defects and Developmental Disabilities, and as a member of the program committee for the International Meeting for Autism Research (IMFAR). Ms. Singer graduated magna cum laude from Yale University with a B.A. in Economics and has an M.B.A. from Harvard Business School.
The following individuals serve as alternates for IACC federal members.
Silvana Borges, M.D. (Representing Tiffany R. Farchione, M.D.)Acting Team Leader, U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research Division of Psychiatry Products
Dr. Borges received her Medical Degree from the State University School of Medicine in Uruguay. She completed her medical residency and got board certified in Child & Adolescent Psychiatry. She joined the Department of Pharmacology and Therapeutics in the State University School of Medicine as an Assistant Professor and then became an Assistant Professor and Founding Member of the "National Center for Drug Safety" in Uruguay. She was a Scholar at the Catalan Institute of Pharmacology (Barcelona, Spain) focusing her training in drug safety and pharmacoepidemiology. She received the Merck Foundation International Fellowship in Clinical Pharmacology Award and completed a fellowship in clinical pharmacology and pharmacogenetics at Indiana University, being mentored by Dr. David Flockhart. She was the recipient of the American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award for her work on the role of CYP2D6 genetic polymorphism on tamoxifen metabolism and its interaction with antidepressants. She is currently Acting Team Leader with the Division of Psychiatry Products, Office of New Drugs, U.S. Food and Drug Administration.
Josie Briggs, M.D. (Representing Francis S. Collins, M.D., Ph.D.)Director, National Center for Complementary and Alternative Medicine, National Institutes of Health (NIH)
Dr. Briggs an accomplished researcher and physician, is Director of the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH), the leading Federal agency for research on integrative and complementary health practices.
Dr. Briggs received her A.B. in biology from Harvard-Radcliffe College and her M.D. from Harvard Medical School. She completed her residency training in internal medicine and nephrology at the Mount Sinai School of Medicine, New York, New York, where she was also Chief Resident in the Department of Internal Medicine and a fellow in clinical nephrology. She then held a research fellowship in physiology at Yale School of Medicine, New Haven, Connecticut. Dr. Briggs was a research scientist for 7 years at the Physiology Institute at the University of Munich, Munich, Germany.
In 1985, Dr. Briggs moved to the University of Michigan, Ann Arbor, Michigan, where she held several academic positions including Professor of Internal Medicine and Physiology. Dr. Briggs joined NIH in 1997 as Director of the Division of Kidney, Urologic, and Hematologic Diseases at the National Institute of Diabetes and Digestive and Kidney Diseases, where she oversaw extramural research activities. In 2006, she accepted a position as Senior Scientific Officer at the Howard Hughes Medical Institute, and in 2008, she returned to NIH to accept her current position as Director of NCCAM.
At NIH, in addition to leadership of NCCAM, she has served as Acting Director of the Division of Clinical Innovation in the newly established National Center for Advancing Translational Sciences. Dr. Briggs is also a member of the NIH Steering Committee, the most senior governing board at NIH. She also serves as a member of the NIH Scientific Management Review Board.
Dr. Briggs's research interests include the renin–angiotensin system, circadian regulation of blood pressure, and policy and ethical issues around clinical research. She has published more than 175 research articles, book chapters, and other scholarly publications. Dr. Briggs also has served on the editorial boards of several journals and was Deputy Editor of the Journal of Clinical Investigation. She is an elected member of the Association of American Physicians and the American Society for Clinical Investigation and a fellow of the American Association for the Advancement of Science. She is a recipient of many awards and prizes, including the Volhard Prize of the German Society of Nephrology, the Alexander von Humboldt Scientific Exchange Award, and NIH Director's Awards for her role in the development of the Trans-NIH Type I Diabetes Strategic Plan, her leadership of the Trans-NIH Zebrafish Committee, and her direction of the NIH Health Care Systems Research Collaboratory.
Judith A. Cooper, Ph.D. (Representing James F. Battey, M.D., Ph.D.)Deputy Director, National Institute on Deafness and Other Communication Disorders (NIDCD); Director, Division of Scientific Programs, National Institutes of Health (NIH)
Dr. Cooper is currently Deputy Director of the National Institute on Deafness and Other Communication Disorders at the NIH. In addition, she serves as Director, Division of Scientific Programs, within NIDCD, and finally, she has programmatic responsibilities for the areas of language, language impairments, and language in deaf individuals. She received her B.F.A. at Southern Methodist University in 1971 with a major in Speech-Language Pathology, her M.S. in Speech-Language Pathology at Vanderbilt University in 1972, and her Ph.D. at the University of Washington in 1982 in Speech and Hearing Sciences. She was elected a Fellow of the American Speech-Language-Hearing Association in 2006 and received the Honors of the Association in 2007.
Dr. Copper joined the National Institutes of Health as a Health Scientist Administrator (HSA) within the National Institute of Neurological and Communicative Disorders and Stroke in November, 1982. Dr. Cooper became an HSA within the National Institute on Deafness and Other Communication Disorders, upon its establishment in October, 1988; subsequently served as Deputy Director as well as acting director of the Division of Human Communication; Chief, Scientific Programs Branch; and has been in her current position since January, 2004.
Dr. Cooper's current responsibilities include overseeing and coordinating the activities of her division; advising within NIDCD and across the NIH regarding issues related to language and language disorders; participating in trans-NIH initiatives focused in language as well as autism; and, working with potential and funded researchers in language across the US and beyond, providing advice, direction, and encouragement related to research grant focus, development and preparation.
Alice Kau, Ph.D. (Representing Alan E. Guttmacher, M.D.)Health Scientist Administrator, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Dr. Kau joined the Intellectual and Developmental Disabilities Branch as a Health Scientist Administrator in June 2003. Dr. Kau is responsible for the Branch's Biobehavioral Research Program with emphasis on autism research. She also serves as a key member of the autism and behavioral science research communities on behalf of the Branch and assists in formulating and planning activities of these programs. Dr. Kau received her doctorate in developmental psychology from Ohio State University and completed a postdoctoral fellowship in clinical psychology at the Department of Pediatrics at the Johns Hopkins University School of Medicine. Prior to coming to the NICHD, Dr. Kau was an assistant professor/of psychology at the Kennedy Krieger Institute, Johns Hopkins University.
Cindy Lawler, Ph.D. (Representing Linda Birnbaum, Ph.D.)Chief, Genes, Environment and Health Branch, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH)
Dr. Lawler is Chief of the Genes, Environment and Health Branch in the Division of Extramural Research and Training. She is the lead NIEHS representative for extramural autism activities and manages a number of extramural grants that address the contribution of the environment and gene-environment interaction in autism etiology. Dr. Lawler also has responsibility for the NIEHS extramural portfolio of epidemiologic research in Parkinson's disease.
She received her Ph.D. in experimental psychology at Northeastern University and received postdoctoral training in the Brain and Development Research Center at the University of North Carolina at Chapel Hill (UNC-CH). Prior to joining NIEHS, Lawler was a faculty member in the UNC-CH Department of Psychiatry and the Program in Toxicology and held an adjunct appointment in the Department of Biostatistics. She served as a Principal Investigator on an NIH-supported research grant in behavioral neuroscience, with an emphasis on dopamine receptor pharmacology and development of novel pharmacologic agents to treat diseases and disorders related to altered dopamine neurotransmission.
Shantel E. Meek, Ph.D. (Representing Linda K. Smith)Policy Advisor, Early Childhood Development, Administration for Children and Families (ACF)
Dr. Meek serves as a Policy Advisor for Early Childhood Development in the Administration for Children and Families at the U.S. Department of Health and Human Services (HHS). In her role, Dr. Meek advises the Deputy Assistant Secretary for Early Childhood Development on a wide array of research areas and policy issues, including parent and community engagement, promoting healthy child development, and supporting young children with disabilities. Prior to her work at HHS, Dr. Meek served as a Clinical Interventionist for children with autism spectrum disorder (ASD) and their families at the Southwest Autism Research and Resource Center (SARRC). In this capacity, she worked one-on-one with children, performed educational consultation and inclusion support services, and trained parents and paraprofessionals on empirically supported techniques aimed at improving social, emotional, cognitive, motor and self-help skills in young children with ASD. Dr. Meek's research activities are focused on the healthy social-emotional and cognitive development of young children in poverty and young children with developmental disabilities. Dr. Meek's work related to the social development of children with ASD has been published in peer-reviewed journals. She holds a B.A. in Psychology and a Ph.D. in Family and Human Development from Arizona State University.
Shui-Lin (Stan) Niu, Ph.D. (Representing Donna M. Kimbark, Ph.D.)Science Officer, Congressionally Directed Medical Research Programs, U.S. Department of Defense (DoD)
Dr. Niu is the Science Officer for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense, where he manages a broad portfolio of biomedical research programs including Autism Research Program, Bone Marrow Failure Research Program, Peer-reviewed Cancer Research Program, Traumatic Brain Injury and Psychological Health. He is recently elected as the chair for the SBIR/STTR program. His current portfolio consists of 160 research awards with over $60 million dollars. Prior to coming to CDMRP in 2010, Dr. Niu worked as a Technology Transfer Specialist where he managed intellectual properties and as a Staff Scientist where he studied polyunsaturated omega-3 fatty acids and G protein coupled receptor function at NIH. He published 22 peer-reviewed scientific papers. Dr. Niu received a B.S in Organic Chemistry from Tongji University and a Ph.D. in Biophysics from University of Hawaii.
Hae Young Park, M.P.H. (Representing Laura Kavanagh, M.P.P.)Senior Public Health Analyst, Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration (HRSA)
Hae Young Park is a Senior Public Health Analyst with the Maternal and Child Health (MCH) Research Program, Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration (HRSA). Ms. Park oversees grant and cooperative agreement programs including the Autism Intervention Research Network on Physical Health, Developmental Behavioral Pediatrics Research Network, and R40 MCH research grants. Ms. Park has been with MCHB since 2000.
Cathy Rice, Ph.D. (Representing Coleen Boyle, Ph.D., M.S. Hyg.)Behavioral Scientist, Developmental Psychologist, Prevention Research Branch, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC)
Dr. Rice is a Behavioral Scientist and Developmental Psychologist with the Prevention Research Branch at the National Center on Birth Defects and Developmental Disabilities at the Centers for Disease Control and Prevention (CDC). She works with the Learn the Signs-Act Early Team to improve the early identification of children with autism and other developmental disabilities. She has worked with people with an Autism Spectrum Disorder (ASD) through teaching, diagnostic assessment, program planning, consultation, training, and research for over 20 years. Dr. Rice's work at CDC has included working with partners to track the rates and describe the population of children with an ASD in multiple areas of the United States through the Autism Developmental Disabilities Monitoring (ADDM) Network. Dr. Rice is an Adjunct Assistant Professor at the Emory University Department of Psychiatry and Behavioral Sciences. She serves on Advisory Boards for Autism Speaks, New Jersey Governor's Council for Autism Science, the Emory Autism Center, and the Atlanta Autism Consortium. Dr. Rice conducts training to professionals on the diagnosis and assessment of people with an ASD. She received her undergraduate degree in Psychology from Emory University and her doctorate in Developmental Psychology from Boston College. She was named the Autism Society of America Professional of the Year in 2008. Dr. Rice is a member of the American Psychological Association, the Georgia Psychological Association, the Society for Research in Child Development, and the International Society for Autism Research and is a licensed Psychologist in the state of Georgia.
Lawrence J. Wexler, Ed.D. (Representing Michael K. Yudin)Director, Research to Practice Division, U.S. Department of Education, Office of Special Education and Rehabilitative Services (OSEP)
Dr. Wexler is the Director of the Research to Practice Division in the Office of Special Education Programs (OSEP), U.S. Department of Education. The Research to Practice Division provides leadership and oversees the implementation of the IDEA discretionary grant programs to support seven grant programs: state personnel development; personnel preparation; technical assistance and dissemination; technology, media services and educational materials, parent-training and information centers; IDEA data; and the Promoting Readiness for Minors In Special Education.
Dr. Wexler has been a special educator for forty four years having been a teacher of students with severe disabilities, program director, principal, state intellectual disabilities specialist, chief of staff to the State Director of Special Education, director of state monitoring, OSEP state contact, OSEP project officer, Deputy Director of the Monitoring and State Improvement Planning Division and Associate Division Director responsible for OSEP's National Initiatives Team.
He holds a Bachelor's degree in International Relations from the School of International Service at American University, a Master's degree in teaching with concentration in mental retardation from Howard University and a Doctorate with concentration in severe disabilities from the Johns Hopkins University.